Rights and permissions
About this article
Cite this article
CMV immune globulin titre-guided regimen cost effective. Pharmacoecon. Outcomes News 20, 11 (1995). https://doi.org/10.1007/BF03293683
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03293683